An Analysis of Major Target Deviations in Craniospinal Irradiation Treatment Plans for Patients With Intermediate-Risk Medulloblastoma Within a Phase 3 Clinical Trial (Children's Oncology Group Study ACNS0331)

An Analysis of Major Target Deviations in Craniospinal Irradiation Treatment Plans for Patients With Intermediate-Risk Medulloblastoma Within a Phase 3 Clinical Trial (Children's Oncology Group Study ACNS0331)

Purpose: Craniospinal irradiation remains an essential and yet difficult part of the treatment of patients with medulloblastoma. Whereas technological advances offer promise of increased conformity, realiance on advanced technology is not without risk, and it remains critical to carefully delineate...

Full description

Bibliographic Details
Main Authors: Joshua P. Schiff, MD, Yimei Lee, MS, Yu Wang, MS, Stephanie M. Perkins, MD, Sandy K. Kessel, MD, Thomas J. Fitzgerald, MD, Nicole A. Larrier, MD, Jeff M. Michalski, MD, MBA
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109422001890

Internet

http://www.sciencedirect.com/science/article/pii/S2452109422001890

Similar Items